GGrantIndex
← Leaderboards

Stuart E Starr

Children'S Hospital Of Philadelphia

$1,873,719
Attributed
$1,873,719
Total exposure
9
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$1,873,719 · 9

By mechanism

U01$1,686,474 · 1
M01$187,245 · 8

Top collaborators

No co-investigators on record.

Most similar at Children'S Hospital Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectHuman Therapy EvaluationHiv InfectionsAids TherapyChild (0-11)Pediatric AidsClinical Trial Phase IAids VaccinesClinical TrialsOutcomes ResearchImmunotherapyAids Education /PreventionNevirapineHuman Immunodeficiency Virus 1Drug Screening /EvaluationVertical TransmissionPediatric PharmacologyPharmacokineticsAntiviral AgentsCombination ChemotherapyAntiaids AgentChemopreventionCytomegalovirus

Grant awards (18)

ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS$186,685
M01 · FY2002 · RR
HIV VACCINE, AIDSVAX B/B IN CHILDREN OF HIV+ MOTHERS$0
M01 · FY2002 · RR
PHASE I/II TRIAL OF CD4-IGG2 IN HIV INFECTED CHILDREN$0
M01 · FY2002 · RR
ACTG 382--DMP 266 IN COMBINATION WITH NELFINAVIR IN HIV INFECTED CHILDREN$0
M01 · FY2002 · RR
ACTG 316--NEVIRAPINE VS NEVIRAPINE PLACEBO FOR PREVENTION OF MATERNAL/FETAL HIV$0
M01 · FY2002 · RR
SAFETY AND IMMUNOGENICITY OF CANARYPOX CMV (VCP260) IN HEALTHY ADULTS$0
M01 · FY2002 · RR
ACT 299--RECOMBINANT INTERLEUKIN 2 IN SYMPTOMATIC HIV INFECTED CHILDREN$0
M01 · FY2002 · RR
ACTG 265--LIVE ATTENTUATED VARICELLA VACCINE IN HIV INFECTION CHILDREN$0
M01 · FY2002 · RR
PHILADELPHIA PEDIATRIC AIDS CLINICAL TRIALS UNIT$890,498
U01 · FY2001 · AI
PHILADELPHIA PEDIATRIC AIDS CLINICAL TRIALS UNIT$795,976
U01 · FY2000 · AI
ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS$560
M01 · FY2000 · RR
PHASE I/II TRIAL OF CD4-IGG2 IN HIV INFECTED CHILDREN$0
M01 · FY2000 · RR
ACTG 382--DMP 266 IN COMBINATION WITH NELFINAVIR IN HIV INFECTED CHILDREN$0
M01 · FY2000 · RR
ACTG 316--NEVIRAPINE VS NEVIRAPINE PLACEBO FOR PREVENTION OF MATERNAL/FETAL HIV$0
M01 · FY2000 · RR
SAFETY AND IMMUNOGENICITY OF CANARYPOX CMV (VCP260) IN HEALTHY ADULTS$0
M01 · FY2000 · RR
ACT 299--RECOMBINANT INTERLEUKIN 2 IN SYMPTOMATIC HIV INFECTED CHILDREN$0
M01 · FY2000 · RR
ACTG 265--LIVE ATTENTUATED VARICELLA VACCINE IN HIV INFECTION CHILDREN$0
M01 · FY2000 · RR
HIV VACCINE, AIDSVAX B/B IN CHILDREN OF HIV+ MOTHERS$0
M01 · FY2000 · RR